1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cloud based 1.2.3 On-premises 1.3 Market by Application 1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharma and Biotech 1.3.3 Contract Research Organizations (CROs) 1.3.4 Business Process Outsourcing (BPO) Firms 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Perspective (2016-2027) 2.2 Pharmacovigilance (PV) and Drug Safety Software Growth Trends by Regions 2.2.1 Pharmacovigilance (PV) and Drug Safety Software Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharmacovigilance (PV) and Drug Safety Software Historic Market Share by Regions (2016-2021) 2.2.3 Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Regions (2022-2027) 2.3 Pharmacovigilance (PV) and Drug Safety Software Industry Dynamic 2.3.1 Pharmacovigilance (PV) and Drug Safety Software Market Trends 2.3.2 Pharmacovigilance (PV) and Drug Safety Software Market Drivers 2.3.3 Pharmacovigilance (PV) and Drug Safety Software Market Challenges 2.3.4 Pharmacovigilance (PV) and Drug Safety Software Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmacovigilance (PV) and Drug Safety Software Players by Revenue 3.1.1 Global Top Pharmacovigilance (PV) and Drug Safety Software Players by Revenue (2016-2021) 3.1.2 Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Players (2016-2021) 3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharmacovigilance (PV) and Drug Safety Software Revenue 3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market Concentration Ratio 3.4.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) and Drug Safety Software Revenue in 2020 3.5 Pharmacovigilance (PV) and Drug Safety Software Key Players Head office and Area Served 3.6 Key Players Pharmacovigilance (PV) and Drug Safety Software Product Solution and Service 3.7 Date of Enter into Pharmacovigilance (PV) and Drug Safety Software Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacovigilance (PV) and Drug Safety Software Breakdown Data by Type 4.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Type (2016-2021) 4.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Type (2022-2027) 5 Pharmacovigilance (PV) and Drug Safety Software Breakdown Data by Application 5.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Application (2016-2021) 5.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027) 6.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type 6.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) 6.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) 6.2.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2027) 6.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application 6.3.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) 6.3.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) 6.3.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2027) 6.4 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country 6.4.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) 6.4.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027) 7.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type 7.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) 7.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) 7.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2027) 7.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application 7.3.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) 7.3.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) 7.3.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2027) 7.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country 7.4.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) 7.4.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027) 8.2 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Type 8.2.1 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2027) 8.3 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Application 8.3.1 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2027) 8.4 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region 8.4.1 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027) 9.2 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type 9.2.1 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) 9.2.2 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) 9.2.3 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2027) 9.3 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application 9.3.1 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) 9.3.2 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) 9.3.3 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2027) 9.4 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country 9.4.1 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) 9.4.2 Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027) 10.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type 10.2.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2027) 10.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application 10.3.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2027) 10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country 10.4.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AB Cube 11.1.1 AB Cube Company Details 11.1.2 AB Cube Business Overview 11.1.3 AB Cube Pharmacovigilance (PV) and Drug Safety Software Introduction 11.1.4 AB Cube Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.1.5 AB Cube Recent Development 11.2 Sparta Systems, Inc. 11.2.1 Sparta Systems, Inc. Company Details 11.2.2 Sparta Systems, Inc. Business Overview 11.2.3 Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction 11.2.4 Sparta Systems, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.2.5 Sparta Systems, Inc. Recent Development 11.3 Oracle Corporation 11.3.1 Oracle Corporation Company Details 11.3.2 Oracle Corporation Business Overview 11.3.3 Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Introduction 11.3.4 Oracle Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.3.5 Oracle Corporation Recent Development 11.4 EXTEDO GmbH 11.4.1 EXTEDO GmbH Company Details 11.4.2 EXTEDO GmbH Business Overview 11.4.3 EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Introduction 11.4.4 EXTEDO GmbH Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.4.5 EXTEDO GmbH Recent Development 11.5 Ennov Solutions, Inc. 11.5.1 Ennov Solutions, Inc. Company Details 11.5.2 Ennov Solutions, Inc. Business Overview 11.5.3 Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction 11.5.4 Ennov Solutions, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.5.5 Ennov Solutions, Inc. Recent Development 11.6 ArisGlobal 11.6.1 ArisGlobal Company Details 11.6.2 ArisGlobal Business Overview 11.6.3 ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Introduction 11.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.6.5 ArisGlobal Recent Development 11.7 United BioSource Corporation 11.7.1 United BioSource Corporation Company Details 11.7.2 United BioSource Corporation Business Overview 11.7.3 United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Introduction 11.7.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.7.5 United BioSource Corporation Recent Development 11.8 Online Business Applications, Inc. 11.8.1 Online Business Applications, Inc. Company Details 11.8.2 Online Business Applications, Inc. Business Overview 11.8.3 Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction 11.8.4 Online Business Applications, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) 11.8.5 Online Business Applications, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cloud based Table 3. Key Players of On-premises Table 4. Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions (2016-2021) Table 8. Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions (2022-2027) Table 10. Pharmacovigilance (PV) and Drug Safety Software Market Trends Table 11. Pharmacovigilance (PV) and Drug Safety Software Market Drivers Table 12. Pharmacovigilance (PV) and Drug Safety Software Market Challenges Table 13. Pharmacovigilance (PV) and Drug Safety Software Market Restraints Table 14. Global Pharmacovigilance (PV) and Drug Safety Software Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Players (2016-2021) Table 16. Global Top Pharmacovigilance (PV) and Drug Safety Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) and Drug Safety Software as of 2020) Table 17. Ranking of Global Top Pharmacovigilance (PV) and Drug Safety Software Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Pharmacovigilance (PV) and Drug Safety Software Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Pharmacovigilance (PV) and Drug Safety Software Product Solution and Service Table 21. Date of Enter into Pharmacovigilance (PV) and Drug Safety Software Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million) Table 24. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Type (2016-2021) Table 25. Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Pharmacovigilance (PV) and Drug Safety Software Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Application (2016-2021) Table 29. Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million) Table 32. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million) Table 34. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million) Table 61. AB Cube Company Details Table 62. AB Cube Business Overview Table 63. AB Cube Pharmacovigilance (PV) and Drug Safety Software Product Table 64. AB Cube Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 65. AB Cube Recent Development Table 66. Sparta Systems, Inc. Company Details Table 67. Sparta Systems, Inc. Business Overview Table 68. Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Table 69. Sparta Systems, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 70. Sparta Systems, Inc. Recent Development Table 71. Oracle Corporation Company Details Table 72. Oracle Corporation Business Overview Table 73. Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Product Table 74. Oracle Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 75. Oracle Corporation Recent Development Table 76. EXTEDO GmbH Company Details Table 77. EXTEDO GmbH Business Overview Table 78. EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Product Table 79. EXTEDO GmbH Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 80. EXTEDO GmbH Recent Development Table 81. Ennov Solutions, Inc. Company Details Table 82. Ennov Solutions, Inc. Business Overview Table 83. Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Table 84. Ennov Solutions, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 85. Ennov Solutions, Inc. Recent Development Table 86. ArisGlobal Company Details Table 87. ArisGlobal Business Overview Table 88. ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Product Table 89. ArisGlobal Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 90. ArisGlobal Recent Development Table 91. United BioSource Corporation Company Details Table 92. United BioSource Corporation Business Overview Table 93. United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Product Table 94. United BioSource Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 95. United BioSource Corporation Recent Development Table 96. Online Business Applications, Inc. Company Details Table 97. Online Business Applications, Inc. Business Overview Table 98. Online Business Applications, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) & (US$ Million) Table 99. Online Business Applications, Inc. Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Type: 2020 VS 2027 Figure 2. Cloud based Features Figure 3. On-premises Features Figure 4. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Application: 2020 VS 2027 Figure 5. Pharma and Biotech Case Studies Figure 6. Contract Research Organizations (CROs) Case Studies Figure 7. Business Process Outsourcing (BPO) Firms Case Studies Figure 8. Other Case Studies Figure 9. Pharmacovigilance (PV) and Drug Safety Software Report Years Considered Figure 10. Global Pharmacovigilance (PV) and Drug Safety Software Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Pharmacovigilance (PV) and Drug Safety Software Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions: 2020 VS 2027 Figure 13. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions (2022-2027) Figure 14. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Players in 2020 Figure 15. Global Top Pharmacovigilance (PV) and Drug Safety Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) and Drug Safety Software as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) and Drug Safety Software Revenue in 2020 Figure 17. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Type (2016-2021) Figure 18. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Type (2022-2027) Figure 19. North America Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2027) Figure 21. North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2027) Figure 22. North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Country (2016-2027) Figure 23. United States Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2027) Figure 27. Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2027) Figure 28. Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Country (2016-2027) Figure 29. Germany Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2027) Figure 37. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2027) Figure 38. Asia-Pacific Pharmacovigilance (PV) and Drug Safety Software Market Share by Region (2016-2027) Figure 39. China Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2027) Figure 47. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2027) Figure 48. Latin America Pharmacovigilance (PV) and Drug Safety Software Market Share by Country (2016-2027) Figure 49. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2027) Figure 53. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2027) Figure 54. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Share by Country (2016-2027) Figure 55. Turkey Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. AB Cube Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 59. Sparta Systems, Inc. Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 60. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 61. EXTEDO GmbH Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 62. Ennov Solutions, Inc. Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 63. ArisGlobal Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 64. United BioSource Corporation Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 65. Online Business Applications, Inc. Revenue Growth Rate in Pharmacovigilance (PV) and Drug Safety Software Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

AB Cube Sparta Systems, Inc. Oracle Corporation EXTEDO GmbH Ennov Solutions, Inc. ArisGlobal United BioSource Corporation Online Business Applications, Inc.